Novavax Inc. closed 64.88% below its 52-week high of $23.86, which the company reached on June 6th.

Shares of Novavax (NVAX) have gained 3.5% over the past four weeks to close the last trading session at $8.81, but there could still be a solid upside left in the stock if short-term price targets ...

Novavax Stock Prediction For 2025 Equity research can ... while the street low from HC Wainwright & Co. is $19.0. Price Action: NVAX stock is up 10.4% at $8.08 at the last check Thursday.

Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, the company’s earnings beat estimates by 12.64%. The Zacks Consensus ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Company granted a non- qualified stock option and restricted stock units to ...

Novavax (NASDAQ:NVAX) shares traded marginally higher on Thursday in the premarket after the Gaithersburg, Maryland-based biotech exceeded Street forecasts with its Q4 2024 revenue despite an ~80% ...

The Zacks Earnings ESP, Explained The Zacks Expected Surprise Prediction ... want to take a look at Novavax (NVAX) as well. Novavax is a Zacks Rank #3 (Hold) stock, and is getting ready to ...

Novavax NVAX is expected to report fourth-quarter ... Our proven model does not predict an earnings beat for Novavax this time around. The combination of a positive Earnings ESP and a Zacks ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...